Berkeley Catalyst — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Frontier Medicines is a drug discovery company that combines chemoproteomics and AI to develop covalent small-molecule therapeutics against difficult-to-drug protein targets.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Chris Varma, Ph.D.(Executive Officer, Director)Chris Varma(Co-founder, Chairman and CEO)Jim Winkler(Executive Officer)Johannes Hermann, Ph.D.(Executive Officer)Kevin Webster(Executive Officer)Gregory Chow(Executive Officer)
Co-investorsDCVC (Data Collective)Droia VenturesMPM BioImpactRA CapitalDCVC BioDeerfield Management Company
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.